
QR-linked, AI-guided pharmaceutical therapies powered by the Adaptive Adherence Intelligence Engine
Telmisartan 40 mg & Amlodipine 5 mg Tablets
Dual-action antihypertensive combining an ARB and calcium channel blocker. Features circadian-optimized morning dosing with AI-guided food interaction management.
Metformin Hydrochloride IP 500 mg Tablets
First-line oral hypoglycemic for Type 2 Diabetes. Features dawn-phenomenon targeted dosing with AI glucose monitoring, food interaction alerts, and adherence tracking.
Coming Soon
New therapy in development. Check back for updates on our expanding portfolio of AI-guided pharmaceutical solutions.